• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗SARS-CoV-2抗体的持久性取决于分析试剂盒:感染后长达10个月的报告。

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection.

作者信息

Favresse Julien, Eucher Christine, Elsen Marc, Gillot Constant, Van Eeckhoudt Sandrine, Dogné Jean-Michel, Douxfils Jonathan

机构信息

Department of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium.

Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, 5000 Namur, Belgium.

出版信息

Microorganisms. 2021 Mar 8;9(3):556. doi: 10.3390/microorganisms9030556.

DOI:10.3390/microorganisms9030556
PMID:33800489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8001517/
Abstract

Several studies have described the long-term kinetics of anti-SARS-CoV-2 antibodies but long-term follow-up data, i.e., >6 months, are still sparse. Additionally, the literature is inconsistent regarding the waning effect of the serological response. The aim of this study was to explore the temporal dynamic changes of the immune response after SARS-CoV-2 infection in hospitalized and non-hospitalized symptomatic patients over a period of 10 months. Six different analytical kits for SARS-CoV-2 antibody detection were used. Positivity rates, inter-assay agreement and kinetic models were determined. A high inter-individual and an inter-methodology variability was observed. Assays targeting total antibodies presented higher positivity rates and reached the highest positivity rates sooner compared with assays directed against IgG. The inter-assay agreement was also higher between these assays. The stratification by disease severity showed a much-elevated serological response in hospitalized versus non-hospitalized patients in all assays. In this 10-month follow-up study, serological assays showed a clinically significant difference to detect past SARS-CoV-2 infection with total antibody assays presenting the highest positivity rates. The waning effect reported in several studies should be interpreted with caution because it could depend on the assay considered.

摘要

多项研究描述了抗SARS-CoV-2抗体的长期动力学,但长期随访数据,即超过6个月的数据仍然稀少。此外,关于血清学反应减弱效应的文献并不一致。本研究的目的是探讨住院和非住院有症状患者在感染SARS-CoV-2后10个月内免疫反应的时间动态变化。使用了六种不同的SARS-CoV-2抗体检测分析试剂盒。测定了阳性率、检测间一致性和动力学模型。观察到个体间和方法间存在高度变异性。与针对IgG的检测相比,针对总抗体的检测呈现出更高的阳性率,且更早达到最高阳性率。这些检测之间的检测间一致性也更高。按疾病严重程度分层显示,在所有检测中,住院患者与非住院患者相比血清学反应明显升高。在这项为期10个月的随访研究中,血清学检测显示,总抗体检测在检测既往SARS-CoV-2感染方面呈现出最高的阳性率,具有临床显著差异。几项研究中报道的减弱效应应谨慎解读,因为它可能取决于所考虑的检测方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/8001517/203b009f8ad5/microorganisms-09-00556-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/8001517/99fde321b0ec/microorganisms-09-00556-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/8001517/203b009f8ad5/microorganisms-09-00556-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/8001517/99fde321b0ec/microorganisms-09-00556-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/8001517/203b009f8ad5/microorganisms-09-00556-g002.jpg

相似文献

1
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection.抗SARS-CoV-2抗体的持久性取决于分析试剂盒:感染后长达10个月的报告。
Microorganisms. 2021 Mar 8;9(3):556. doi: 10.3390/microorganisms9030556.
2
Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies.用商业免疫分析法检测 SARS-CoV-2 核衣壳抗体血清学反应衰减:长达 18 个月的纵向随访研究
Microbiol Spectr. 2022 Aug 31;10(4):e0098622. doi: 10.1128/spectrum.00986-22. Epub 2022 Jul 14.
3
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.SARS-CoV-2 抗体检测在医护人员中的应用:三种市售抗体检测试剂盒的临床性能比较。
Microbiol Spectr. 2021 Oct 31;9(2):e0039121. doi: 10.1128/Spectrum.00391-21. Epub 2021 Sep 29.
4
Persistence of IgG COVID-19 antibodies: A longitudinal analysis.IgG 型 COVID-19 抗体的持久性:一项纵向分析。
Front Public Health. 2023 Jan 10;10:1069898. doi: 10.3389/fpubh.2022.1069898. eCollection 2022.
5
The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.罗氏 Elecsys® 抗 SARS-CoV-2 和 Elecsys® 抗 SARS-CoV-2 S 抗体检测:区分疫苗接种和感染,并评估长期性能。
PLoS One. 2024 Jul 18;19(7):e0305613. doi: 10.1371/journal.pone.0305613. eCollection 2024.
6
Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.SARS-CoV-2 感染后 12 个月内特异性抗 SARS-CoV-2 IgM、IgA 和 IgG 反应的动力学:一项前瞻性纵向研究。
PLoS One. 2023 Jul 12;18(7):e0288557. doi: 10.1371/journal.pone.0288557. eCollection 2023.
7
Sensitivity and Specificity of Anti-SARS-CoV-2 Detection Kits - Comparison and Agreement between Fifteen Different Assays.抗 SARS-CoV-2 检测试剂盒的灵敏度和特异性 - 十五种不同检测方法的比较和一致性。
Jpn J Infect Dis. 2022 Jan 24;75(1):16-23. doi: 10.7883/yoken.JJID.2021.031. Epub 2021 May 31.
8
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
9
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.COVID-19 患者症状出现后七个月内 SARS-CoV-2 特异性和中和抗体的动力学。
Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22.
10
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.用于鉴定 SARS-CoV-2 感染血清学特征的多重分析:基于抗体的诊断和机器学习研究。
Lancet Microbe. 2021 Feb;2(2):e60-e69. doi: 10.1016/S2666-5247(20)30197-X. Epub 2020 Dec 21.

引用本文的文献

1
Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021-February 2022.2021 年 1 月至 2022 年 2 月期间,美国既往感染者的 SARS-CoV-2 刺突受体结合域和中和抗体滴度定量分析。
Emerg Infect Dis. 2024 Nov;30(11):2352-2361. doi: 10.3201/eid3011.240043.
2
Characterization of biotinylated human ACE2 and SARS-CoV-2 Omicron BA.4/5 spike protein reference materials.生物素化人血管紧张素转换酶 2 和 SARS-CoV-2 奥密克戎 BA.4/5 刺突蛋白参考物质的特性分析。
Anal Bioanal Chem. 2024 Sep;416(22):4861-4872. doi: 10.1007/s00216-024-05413-7. Epub 2024 Jun 28.
3

本文引用的文献

1
Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination.新型冠状病毒2感染后体液免疫反应的动力学及生物学特性:对疫苗接种的启示
Clin Chem Lab Med. 2021 Jan 22;59(8):1333-1335. doi: 10.1515/cclm-2021-0038. Print 2021 Jul 27.
2
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.SARS-CoV-2 记忆 B 细胞反应的成熟和持久性。
Cell. 2021 Mar 4;184(5):1201-1213.e14. doi: 10.1016/j.cell.2021.01.050. Epub 2021 Feb 2.
3
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients.
Persistence of SARS-CoV-2-antibodies against N, S and RBD after natural infection.
自然感染后针对N、S和RBD的新冠病毒抗体的持久性。
Iran J Microbiol. 2023 Dec;15(6):803-810. doi: 10.18502/ijm.v15i6.14161.
4
The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance.在暴露人群中检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体受所用免疫测定法的影响:对血清学监测的启示
Pathogens. 2023 Nov 16;12(11):1360. doi: 10.3390/pathogens12111360.
5
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison.研究商业 SARS-CoV-2 检测试剂盒的时间效价演变揭示了使用 BAU 标准化进行比较的显著缺陷。
Virol J. 2023 Sep 1;20(1):200. doi: 10.1186/s12985-023-02167-z.
6
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome.新冠病毒感染后综合征患者的 SARS-CoV-2 特异性抗体水平升高。
Viruses. 2023 Mar 8;15(3):701. doi: 10.3390/v15030701.
7
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies.COVID-19 患者一年随访结果表明,SARS-CoV-2 抗体的动力学存在显著的检测依赖性差异。
Microbiol Spectr. 2022 Dec 21;10(6):e0059722. doi: 10.1128/spectrum.00597-22. Epub 2022 Oct 12.
8
Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.腺病毒载体 ChAdOx1 nCoV-19(阿斯利康-牛津)-BNT162b2 mRNA 疫苗异源接种对肺移植受者免疫原性的影响。
Viruses. 2022 Jul 2;14(7):1470. doi: 10.3390/v14071470.
9
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.自然感染和疫苗诱导的免疫对未来感染 SARS-CoV-2 的持久性。
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2204336119. doi: 10.1073/pnas.2204336119. Epub 2022 Jul 15.
10
Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy.意大利翁布里亚地区有症状和无症状人群中 SARS-CoV-2 特异性抗体反应的时间趋势和差异:一项纵向研究。
BMJ Open. 2022 Jul 18;12(7):e056370. doi: 10.1136/bmjopen-2021-056370.
197名住院和非住院COVID-19患者队列中抗SARS-CoV-2抗体的长期动力学
Clin Chem Lab Med. 2020 Dec 18;59(5):e179-e183. doi: 10.1515/cclm-2020-1736. Print 2021 Apr 27.
4
An original multiplex method to assess five different SARS-CoV-2 antibodies.一种评估五种不同 SARS-CoV-2 抗体的原始多重方法。
Clin Chem Lab Med. 2020 Dec 21;59(5):971-978. doi: 10.1515/cclm-2020-1652. Print 2021 Apr 27.
5
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性:俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
6
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.严重急性呼吸综合征冠状病毒 2 感染后数月内中和抗体效价的动态变化。
J Infect Dis. 2021 Feb 3;223(2):197-205. doi: 10.1093/infdis/jiaa618.
7
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
8
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis.比较唾液和鼻咽拭子核酸扩增检测在 SARS-CoV-2 检测中的应用:系统评价和荟萃分析。
JAMA Intern Med. 2021 Mar 1;181(3):353-360. doi: 10.1001/jamainternmed.2020.8876.
9
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.在 COVID-19 和恢复期,针对 SARS-CoV-2 刺突和核衣壳蛋白快速产生持久的 B 细胞记忆。
Sci Immunol. 2020 Dec 22;5(54). doi: 10.1126/sciimmunol.abf8891.
10
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.